WHO ICTRP trial

A Basket Trial of the Safety and Efficacy of Ixekizumab in Participants with…

ChiCTR2200059272 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2200059272
Public title A Basket Trial of the Safety and Efficacy of Ixekizumab in Participants with Autoimmune Inflammatory Skin Diseases
Scientific title A Basket Trial of the Safety and Efficacy of Ixekizumab in Participants with Autoimmune Inflammatory Skin Diseases
Primary sponsor Dermatology Hospital of Southern Medical University
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Phase 2
Countries China
Conditions pityriasis rubra pilaris, hidradenitis suppurativa, Netherton syndrome, erythrokeratodermia variabilis and erythrokeratoderma progressive symmetrica
Interventions pityriasis rubra pilaris, Netherton syndrome, erythrokeratodermia variabilis and erythrokeratoderma progressive symmetrica:Ixekizumab at different doses in adults and juveniles with different body weight;hidradenitis suppurativa:Ixekizumab…
Registration date Apr 27, 2022
Target size pityriasis rubra pilaris, Netherton syndrome, erythrokeratodermia variabilis and…
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations